Researchers at the University of Maryland’s medical school are testing a potential vaccine for E. coli and other diarrheal diseases.

In a news release, the university wrote that Dr. Wilburn Chen and Dr. Eileen Barry will test a vaccine developed at the School of Medicine’s Center for Vaccine Development and Global Health.

The testing is being funded by a $4.5 million agreement with Emergent Biosolutions, “a global life sciences company focused on addressing public health threats, including travel health diseases,” the university wrote.

Read the full story from the Baltimore Sun.